Embryonic chick muscle produces an FGF-like activity

Area of Science:

• Developmental Biology
• Angiogenesis Research
• Molecular Biology

Background:

• Blood vessel formation (angiogenesis) is vital for development and disease.
• Embryonic tissues, particularly muscle, are suitable models for studying angiogenesis.
• Bioassays detect active angiogenic molecules, unlike molecular localization techniques.

Purpose of the Study:

• To investigate angiogenic activity in embryonic chick muscle.
• To identify the specific angiogenic molecules produced by developing muscle.
• To understand the role of these molecules in embryonic vascularization.

Main Methods:

• Utilized bioassays on chick chorioallantoic membrane (CAM) to detect angiogenic activity.
• Assessed the ability of muscle extracts to transform NR6 cells (lacking EGF/TGF-a receptors).
• Employed anti-basic fibroblast growth factor (anti-bFGF) to neutralize specific activity.

Main Results:

• Embryonic chick muscle demonstrated significant angiogenic activity on the CAM.
• Muscle extracts induced NR6 cell transformation, a response characteristic of bFGF.
• Neutralization with anti-bFGF abolished the muscle's transforming activity.

Conclusions:

• Embryonic chick muscle produces an FGF-like molecule with angiogenic properties.
• This molecule plays a role in the vascularization of developing muscle.
• Findings support the persistence of developmental mechanisms in adult angiogenesis.